ArticleEClinicalMedicine2025

Comparative efficacy and safety of CFTR modulators for people with cystic fibrosis with phe508del mutation: a systematic review and bayesian network meta-analysis.

Mohammed Safeer V S et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.